Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00439699 · ClinicalTrials.gov registry record · Phase 4
A Pilot Clinical Trial Of Memantine for Essential Tremor
A Phase 4 study, sponsored by VA Greater Los Angeles Healthcare System.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00439699 is a Phase 4 study that has completed, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 16 participants.
The verdict
NCT00439699, a Phase 4 study, has completed, sponsored by VA Greater Los Angeles Healthcare System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain information on whether or not the medication Memantine reduces tremor in persons with essential tremor and is well-tolerated.
Interventions
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00439699
The ClinicalTrials.gov registry entry for NCT00439699 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Greater Los Angeles Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Memantine is the first listed.
NCT00439699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00439699 about?
NCT00439699 is a clinical study titled "A Pilot Clinical Trial Of Memantine for Essential Tremor". The purpose of this study is to obtain information on whether or not the medication Memantine reduces tremor in persons with essential tremor and is well-tolerated.
What is the current status of trial NCT00439699?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2007-02. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00439699?
The interventions under investigation include: Memantine (DRUG).
Who is sponsoring clinical trial NCT00439699?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.